Net Income (Loss) (USD, thousands)

Stock-based Compensation (USD, thousands)

Depreciation (USD, thousands)

Non-cash Operating Lease Expense (USD, thousands)

Warrants Contra Revenue (USD, thousands)

Inventory Write-downs (USD, thousands)

Accretion of Discounts on Marketable Securities (USD, thousands)

Other, Net (USD, thousands)

Changes in Accounts Receivable, Net (USD, thousands)

Changes in Inventory (USD, thousands)

Changes in Prepaid Expenses and Other Assets (USD, thousands)

Changes in Accounts Payable (USD, thousands)

Changes in Accrued Expenses and Other Liabilities (USD, thousands)

Changes in Operating Lease Liability (USD, thousands)

Net Cash Provided by (Used in) Operating Activities (USD, thousands)

Purchases of Property and Equipment (USD, thousands)

Purchases of Marketable Securities (USD, thousands)

Maturities of Marketable Securities (USD, thousands)

Sales of Marketable Securities (USD, thousands)

Sales and Maturities of Marketable Securities (USD, thousands)

Other Investing Activities (USD, thousands)

Net Cash Used in (Provided by) Investing Activities (USD, thousands)

Proceeds from IPO, Net (USD, thousands)

Payment of Deferred Offering Costs (USD, thousands)

Tax Withholding Related to Net Share Settlements of RSUs (USD, thousands)

Proceeds from Exercises of Stock Options, Net (USD, thousands)

Proceeds from Employee Stock Purchase Plan (USD, thousands)

Repurchase of Common Stock Upon Termination (USD, thousands)

Net Cash Provided by (Used in) Financing Activities (USD, thousands)

Net Increase (Decrease) in Cash and Cash Equivalents (USD, thousands)

Conversion of Preferred Stock into Common Stock (USD, thousands)

Purchases of PP&E in Accounts Payable and Accrued Expenses (USD, thousands)

Income Taxes Paid (USD, thousands)

Cash, Cash Equivalents, and Restricted Cash - Beginning (USD, thousands)

Cash, Cash Equivalents, and Restricted Cash - End (USD, thousands)

Deferred Offering Costs in Accounts Payable and Accrued Expenses (USD, thousands)

Right-of-Use Assets Obtained in Exchange for Lease Obligations (USD, thousands)

68725c975b391b33def59c1f149f31dd1fb299469fd222703d0d3cda4b8123a4

Revenue (USD, thousands)

Cost of revenue (USD, thousands)

Gross profit (USD, thousands)

Gross margin (%)

Operating expenses: Research and development (USD, thousands)

Operating expenses: Sales and marketing (USD, thousands)

Operating expenses: General and administrative (USD, thousands)

Total operating expenses (USD, thousands)

Operating income (loss) (USD, thousands)

Interest income (USD, thousands)

Income (loss) before income taxes (USD, thousands)

Income tax (benefit) provision (USD, thousands)

Net income (loss) (USD, thousands)

Net income (loss) per share attributable to common stockholders: Basic (USD)

Net income (loss) per share attributable to common stockholders: Diluted (USD)

Weighted-average shares used in calculating net income (loss) per share attributable to common stockholders: Basic (thousands)

Weighted-average shares used in calculating net income (loss) per share attributable to common stockholders: Diluted (thousands)

Other comprehensive income (loss): Unrealized gain (loss) on marketable securities, net of taxes (USD, thousands)

Total other comprehensive gain (loss) (USD, thousands)

Total comprehensive income (loss) (USD, thousands)

959246c1d2a08312c4b13e18859e2a0b71cca6b598760fa9538c162f06a9d802

Cash and cash equivalents (USD, thousands)

Marketable securities (USD, thousands)

Accounts receivable, net (USD, thousands)

Inventory (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Other assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Total current liabilities (USD, thousands)

Other liabilities (USD, thousands)

Total liabilities (USD, thousands)

Redeemable convertible preferred stock (USD, thousands)

Common stock (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive income (loss) (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders’ equity (deficit) (USD, thousands)

Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit) (USD, thousands)

Astera Labs Inc (ALAB)

Financials